We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

124 hedge funds and large institutions have $440M invested in Immunomedics Inc in 2017 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 39 increasing their positions, 32 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 15

99% more capital invested

Capital invested by funds: $221M → $440M (+$219M)

86% more call options, than puts

Call options by funds: $21.2M | Put options by funds: $11.4M

22% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 32

14% more funds holding

Funds holding: 109 → 124 (+15)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
124
Holders Change
+15
Holders Change %
+13.76%
% of All Funds
3.09%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
36
Increased
39
Reduced
32
Closed
15
Calls
$21.2M
Puts
$11.4M
Net Calls
+$9.85M
Net Calls Change
+$622K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$40.1M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$23.2M
3
FCM
Farallon Capital Management
California
+$21M
4
RG
Redmile Group
California
+$17.1M
5
State Street
State Street
Massachusetts
+$9.64M

Top Sellers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
-$21.3M
2
O
OrbiMed
New York
-$13M
3
TCP
Tourbillon Capital Partners
New York
-$8.81M
4
Millennium Management
Millennium Management
New York
-$5.26M
5
JGC
J. Goldman & Co
New York
-$3.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$2.7M +$1.35M +266,953 +178%
PAM
27
Panagora Asset Management
Massachusetts
$2.43M +$291K +57,534 +18%
Morgan Stanley
28
Morgan Stanley
New York
$2.37M -$261K -51,600 -12%
CEP
29
Chicago Equity Partners
Illinois
$2.35M +$647K +127,700 +54%
IHM
30
Iguana Healthcare Management
New York
$2.27M +$253K +50,000 +17%
B
31
Bailard
California
$2.04M – – –
Citadel Advisors
32
Citadel Advisors
Florida
$1.95M +$1.53M +301,627 New
PA
33
Perceptive Advisors
New York
$1.94M +$1.52M +300,060 New
Wells Fargo
34
Wells Fargo
California
$1.86M -$121K -23,928 -8%
Ameriprise
35
Ameriprise
Minnesota
$1.72M +$1.35M +266,233 New
TCIM
36
TIAA CREF Investment Management
New York
$1.72M -$63.1K -12,464 -4%
DCM
37
DAFNA Capital Management
California
$1.63M -$1.56M -307,100 -55%
Deutsche Bank
38
Deutsche Bank
Germany
$1.63M +$965K +190,523 +309%
SSA
39
Schonfeld Strategic Advisors
New York
$1.37M -$1.06M -208,847 -50%
Allianz Asset Management
40
Allianz Asset Management
Germany
$1.31M +$1.02M +201,985 New
Voloridge Investment Management
41
Voloridge Investment Management
Florida
$1.31M +$1.02M +201,870 New
Two Sigma Investments
42
Two Sigma Investments
New York
$1.3M +$703K +138,800 +223%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$1.24M -$43.6K -8,600 -4%
TA
44
Teachers Advisors
New York
$1.23M +$19.6K +3,876 +2%
BCM
45
Bridgeway Capital Management
Texas
$1.22M -$507K -100,000 -35%
CS
46
Credit Suisse
Switzerland
$1.14M +$422K +83,298 +89%
Creative Planning
47
Creative Planning
Kansas
$1.14M +$553K +109,200 +163%
AllianceBernstein
48
AllianceBernstein
Tennessee
$1.13M -$58.3K -11,500 -6%
FCMI
49
Foresite Capital Management III
California
$1.12M +$876K +172,871 New
PPA
50
Parametric Portfolio Associates
Washington
$1.08M +$281K +55,392 +50%
1
2
3 4 5

IMMU Hedge Fund Activity: Q1 2017 in Review

124 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q1 2017, worth a combined $440M — up 99% from $221M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new IMMU positions and 15 closed out — a net gain of 21 holders — while 39 added to existing stakes and 32 trimmed.

The largest buyer was BlackRock, adding an estimated $40.1M. The largest seller was Acuta Capital Partners, cutting an estimated $21.3M.

  • 124 institutional investors held Immunomedics Inc (IMMU) as of Q1 2017, up from 109 in Q4 2016.
  • Funds reported $440M of Immunomedics Inc stock for Q1 2017, up 99% quarter-over-quarter.
  • 36 funds opened new Immunomedics Inc positions in Q1 2017 and 15 closed out, a net change of +21 holders.
  • The largest Immunomedics Inc buyer in Q1 2017 was BlackRock, an estimated $40.1M added.
  • The largest Immunomedics Inc seller in Q1 2017 was Acuta Capital Partners, an estimated $21.3M sold.

Based on aggregated 13F filings for Q1 2017.